Part of the dual effect could also arise from a relieved blockade of GH secretion induced at the hypothalamic-pituitary level, and putatively, serum IGF-I concentration and action may increase in response to prednisolone-induced insulin resistance, whereas it may disrupt IGF-I signaling at the tissue level. Here, GH1 is linked to Insulin resistance.